mHSPC VL

Contemporary Management of Hormone Sensitive Prostate Cancer - Alicia Morgans

Details
Alicia Morgans presents a lecture on the contemporary management strategies for hormone sensitive prostate cancer with a focus on systemic therapy including chemohormonal approaches and the use of abiraterone for metastatic hormone sensitive disease. In the discussion, Alicia compares and contrasts both the CHAARTED and STAMPEDE data and provides an update on treatment today, including evidence ba...

Patients' Quality of Life in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treatment Decisions - Alicia Morgans

Details
Alicia Morgans discusses the role of integrating patients in treatment decisions by incorporating quality of life, in particular when there are multiple treatments available with similar efficacy. Dr. Morgans emphasizes how patients should be included in the conversations and the decisions on treatment selection and considerations on efficacy, safety, and potential toxicities. She reiterates that...

The Role of the Nurse Practitioner in the Treatment of mHSPC - Leanne Schimke

Details
Leanne Schimke begins her presentation discussing the role of the nurse practitioner in the treatment of patients with advanced prostate cancer. She first looks at newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) patients. Also, presented is treatment options for mHSPC and the administration, adverse effects, nursing considerations, and drug interactions of these treatments. Bi...

Treatment Decision Making for the Metastatic Hormone-Sensitive Prostate Cancer Patient Population - Alicia Morgans

Details
Charles Ryan interviews Alicia Morgans on her thoughts about treatment decision making in the metastatic hormone-sensitive prostate cancer (mHSPC) population and changes that are rapidly developing in this area. They review how studies such as CHAARTED, LATITUDE, and STAMPEDE have shaped the current options. The discuss the next sets of data that are expected to further expand treatment options in...

A Review on Practice Informing Prostate Cancer Study Results - Christopher Sweeney

Details
(Length of Conversation: 18 min) Christopher Sweeney and Alicia Morgans review practice informing data released at the ESMO 2018 meeting from the GETUG 12, ERA 223, and STAMPEDE studies. Biographies: Christopher Sweeney, MBBS, Professor of Medicine, Harvard Medical School, Medical Oncologist, Dana-Farber Cancer Institute Alicia Morgans, MD, MPH Related Content: 12-Year Follow-Up of GETUG-12, A Pha...

Your Patient Received ADT Plus Docetaxel for M1 Castration-Sensitive/Naive Disease: Now What? - Christopher Sweeney

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Is There a Role for Treating the Primary in Patients with Metastatic Disease? - Axel Heidenreich

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Definition: Castration-sensitive/Naive Prostate Cancer - Howard Scher

Details
Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer

Chris Sweeney on treatment for M1 castration-sensitive/naive disease

Details
Chris Sweeney presented, "Your Patient received ADT plus docetaxel for M1 castration-sensitive/naive disease- now what?", at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC) in St. Gallen, Switzerland. Dr. Sweeney describes to Alicia Morgans the balancing act of the amount of treatment and the importance of the right treatment at the right time for the right patient without the bioma...

Celestia Higano on Clinical Trials in the M1 Castration-Sensitive /Naive Space

Details
Celestia Higano, MD, presented, "Review of the status of ongoing and unreported clincial trials in the M1 castration-sensitive/naive space at the 2017 Advanced Prostate Cancer Consensus Conference (APCCC), in St. Gallen, Switzerland. Neal Shore, MD, interviews Dr. Higano concluding her presentation to discuss the differences in the studies and when the potential read outs may come. Biographies: Ce...